The influence of age on the responses of serum visfatin and insulin resistance to a single session of endurance exercise

Document Type : original article

Abstract

 
Purpose: The purpose of this study was to investigate the effects of age on the responses of serum visfatin and insulin resistance index to a single session of endurance exercise. Methods: For this reason, 45 male subjects were allocated to three age groups (n=15) of young (20-30 уг, ВМІ:22.9), middle-aged (40-50 yr, BMI:25.9) and old (60-70 yr, ВМІ:26.4). After determining the maximal oxygen consumption (Vo,max), all subjects performed an exercise trial in a separate session encompassed performing 30 minutes of cycling at 60% of Vo₂max which was followed by 30 minutes of passive recovery. Before exercise, immediately after and at the end of 30 minutes recovery three blood samples were taken and were analyzed for determining the glucose, insulin, IL-6 and visfatin concentrations. Insulin resistance index was calculated using the glucose and insulin concentrations. To determine the effects of age on responses of all parameters to exercise and recovery, one way independent ANOVA was used. Results: Data analysis revealed that responses of visfatin to endurance exercise was affected by age (P<0.001). However, effects of age on responses of glucose, insulin, IL-6 and insulin resistance index were not significant (P>0.05). Irrespective of age, a single session of endurance exercise induced significant (P<0.05) changes in all parameters except for IL-6. Conclusion: It could be concluded that age is an effective factor on responses of visfatin to acute endurance exercise and that visfatin has no effect on reductions in insulin resistance index but it might be more an effective factor for energy balance through other pathways.
 

Keywords

References

  1. منابع
  2. Wajchenberg BL. (2000). Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev.21(6):697-738.
  3. Mazzeo RS, Tanaka H. (2001). Exercise prescription for the elderly. Sports Medicine.31(11):809-18.
  4. Ahima RS. Adipose tissue as an endocrine organ. Obesity. 2006;14:242S-9S.
  5. Pagano C, Pilon C, Olivieri M, Mason P, Fabris R, Serra R, et al. (2006). Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. Journal of Clinical Endocrinology & Metabolism.91(8):3165-70.
  6. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. (2005). Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 307(5708):426-30.
  7. Tanaka T, Nabeshima Y-i. (2007). Nampt/PBEF/ Visfatin: a new player in β cell physiology and in metabolic diseases? Cell Metab.6(5):341-3.
  8. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I. (1994). Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol.14(2):1431-7.
  9. Frydelund-Larsen L, Akerstrom T, Nielsen S, Keller P, Keller C, Pedersen BK. (2007). Visfatin mRNA expression in human subcutaneous adipose tissue is regulated by exercise. American Journal of Physiology-Endocrinology And Metabolism. 292(1):E24-E31.
  10. Sommer G, Garten A, Petzold S, Beck-Sickinger A, Bluher M, Stumvoll M, et al. (2008). Visfatin/ PBEF/ Nampt: structure, regulation and potential function of a novel adipokine. Clinical Science. 115:13-23.
  11. Haider D, Schaller G, Kapiotis S, Maier C, Luger A, Wolzt M. (2006). The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia. 49(8):1909-14.
  12. Choi K, Kim J, Cho G, Baik S, Park H, Kim S. (2007). Effect of exercise training on plasma visfatin and eotaxin levels. European Journal of Endocrinology. 157(4):437-42.
  13. Kadoglou N, Fotiadis G, Kapelouzou A, Kostakis A, Liapis C, Vrabas I. (2013). The differential anti‐inflammatory effects of exercise modalities and their association with early carotid atherosclerosis progression in patients with Type 2 diabetes. Diabetic Medicine. 30(2):e41-e50.
  14. Lopez-Bermejo A, Chico-Julià B, Fernàndez-Balsells M, Recasens M, Esteve E, Casamitjana R, et al. (2006). Serum visfatin increases with progressive β-cell deterioration. Diabetes. 55(10): 2871-5.
  15. Arner P. (2006). Editorial: Visfatin—A True Or False Trail To Type 2 Diabetes Mellitus. J Clin Endocrinol Metab. 91(1):28-30.
  16. Sun G, Bishop J, Khalili S, Vasdev S, Gill V, Pace D, et al. (2007). Serum visfatin concentrations are positively correlated with serum triacylglycerols and down-regulated by overfeeding in healthy young men. The American journal of clinical nutrition. 85(2):399-404.
  17. Berndt J, Klöting N, Kralisch S, Kovacs P, Fasshauer M, Schön MR, et al. (2005). Plasma visfatin concentrations and fat depot–specific mRNA expression in humans. Diabetes. 54(10):2911-6.
  18. Varma V, Yao-Borengasser A, Rasouli N, Bodles AM, Phanavanh B, Lee M-J, et al. (2007). Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. Journal of Clinical Endocrinology & Metabolism. 92(2):666-72.
  19. Jürimäe J, Gruodytė R, Saar M, Cicchella A, Stefanelli C, Passariello C, et al. (2011). Plasma visfatin and adiponectin concentrations in physically active adolescent girls: relationships with insulin sensitivity and body composition variables. Journal of Pediatric Endocrinology and Metabolism. 24(7-8):419-25.
  20. Falah S, Kordi Mr, Ahmadizad S, Ravasi AA, Hedayati M. (1390). The effects of 8 weeks of endurance training on resting levels and responses of visfatin and insulin resistance index to acute endurance exercise in diabetics rats Sport Physiology & Management Investigations. 8.
  21. Haider DG, Pleiner J, Francesconi M, Wiesinger GF, Müller M, Wolzt M. (2006). Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes. Journal of Clinical Endocrinology & Metabolism. 91(11):4702-4.
  22. Haus J, Solomon T, Marchetti C, O'Leary V, Gonzalez F, Kirwan J. (2009). Decreased visfatin after exercise training correlates with improved glucose tolerance. Medicine Science in Sports Exercise. 41(6):1255.
  23. Brema I, Hatunic M, Finucane F, Burns N, Nolan J, Haider D, et al. (2008). Plasma visfatin is reduced after aerobic exercise in early onset type 2 diabetes mellitus. Diabetes, Obesity and Metabolism. 10(7):600-2.
  24. Lai A, Chen W, Helm K. (2013). Effects of Visfatin Gene Polymorphism RS4730153 on Exercise-induced Weight Loss of Obese Children and Adolescents of Han Chinese. International journal of biological sciences. 9(1):16.
  25. Aggeloussi S, Theodorou AA, Paschalis V, Nikolaidis MG, Fatouros IG, Owolabi EO, et al. (2012). Adipocytokine levels in children: effects of fatness and training. Pediatr Exerc Sci. 24(3):461-71.
  26. Ahmadizad S, Rahmani H, Bassami M, Tahmasebi W. (1391). Relationship between resting plasma visfatin levels and its changes in response to acute endurance exercise with aerobic fitness and body composition in healthy men.
  27. JÜRIMÄE, R R, J M, P P, T J, P A. (2009). Plasma visfatin and ghrelin response to prolonged sculling in competitive male rowers. Medicine & Science in Sports & Exercise. 41(1).
  28. Vatani DS, Faraji H, Rahimi R, Ahmadizad S. (2011). Acute effect of exercise type on serum visfatin in healthy men. MED SPORT. 65:75-83.
  29. Plinta R, Olszanecka-Glinianowicz M, Drosdzol-Cop A, Chudek J, Skrzypulec-Plinta V. (2012). The effect of three-month pre-season preparatory period and short-term exercise on plasma leptin, adiponectin, visfatin, and ghrelin levels in young female handball and basketball players. J Endocrinol Investig. 35(6):595-601.
  30. Rudwill F, Blanc S, Gauquelin-Koch G, Chouker A, Heer M, Simon C, et al. (2013). Effects of different levels of physical inactivity on plasma visfatin in healthy normal-weight men. Applied Physiology, Nutrition, and Metabolism. 38(999):1-5.
  31. Ahmadizad S, Tahmasebi W, Bassami M, Sajadi M, Fathi I. (1391). Effects of progressive resistance training on plasma visfatin, insulin resistance and effective hormoneson visfatin.
  32. Paolisso G, Rizzo MR, Mazziotti G, Tagliamonte MR, Gambardella A, Rotondi M, et al. (1998). Advancing age and insulin resistance: role of plasma tumor necrosis factor-α. American Journal of Physiology-Endocrinology And Metabolism. 275(2): E294-E9.
  33. Marton O, Koltai E, Nyakas C, Bakonyi T, Zenteno-Savin T, Kumagai S, et al. (2010). Aging and exercise affect the level of protein acetylation and SIRT1 activity in cerebellum of male rats. Biogerontology. 11(6):679-86.
  34. Szoke E, Shrayyef MZ, Messing S, Woerle HJ, van Haeften TW, Meyer C, et al. (2008). Effect of Aging on Glucose Homeostasis Accelerated deterioration of β-cell function in individuals with impaired glucose tolerance. Diabetes Care. 31(3):539-43.
  35. Wolden-Hanson T, Marck BT, Smith L, Matsumoto AM. (1999). Cross-sectional and longitudinal analysis of age-associated changes in body composition of male Brown Norway rats: association of serum leptin levels with peripheral adiposity. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 54(3):B99-B107.
  36. Sacheck JM, Cannon JG, Hamada K, Vannier E, Blumberg JB, Roubenoff R. (2006). Age-related loss of associations between acute exercise-induced IL-6 and oxidative stress. American Journal of Physiology-Endocrinology And Metabolism. 291(2):E340-E9.
  37. Oki K, Yamane K, Kamei N, Nojima H, Kohno N. (2007). Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Clinical endocrinology.67(5):796-800.
  38. Kim J-Y, Bae Y-H, Bae M-K, Kim S-R, Park H-J, Wee H-J, et al. (2009). Visfatin through STAT3 activation enhances IL-6 expression that promotes endothelial angiogenesis. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research.1793(11): 1759-67.
  39. Jackson A, Pollock M. (2004). Generalized equations for predicting body density of men. 1978. The British journal of nutrition. 91(1):161.
  40. Dill D, Costill DL. (1974). Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol.37(2):247-8.
  41. Wallace TM, Levy JC, Matthews DR. (2004). Use and abuse of HOMA modeling. Diabetes Care. 27(6):1487-95.
  42. Ghanbari-Niaki A, Saghebjoo M, Soltani R, Kirwan JP. (2010). Plasma visfatin is increased after high-intensity exercise. Annals of Nutrition and Metabolism. 57(1):3-8.
  43. Davidson MB. (1979). The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism. 28(6):688-705.
  44. Lee DH. Sirt1 as a New Therapeutic Target in Metabolic and Age-Related Diseases. Chonnam Medical Journal. 2010;46(2):67-73.
  45. Nie Y, Erion DM, Yuan Z, Dietrich M, Shulman GI, Horvath TL, et al. (2009). STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nat Cell Biol.11(4):492-500.
  46. Gomez CR, Karavitis J, Palmer JL, Faunce DE, Ramirez L, Nomellini V, et al. (2010). Interleukin-6 contributes to age-related alteration of cytokine production by macrophages. Mediat Inflamm.
  47. Mahbub S, Deburghgraeve CR, Kovacs EJ. (2012). Advanced age impairs macrophage polarization. J Interferon Cytokine Res. 32(1):18-26.
  48. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, et al. (2005). Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol. 185(3):R1-R8.
  49.  

Files

History

  • Receive Date: 17 May 2015
  • Revise Date: 18 June 2024
  • Accept Date: 31 December 2020
  • First Publish Date: 31 December 2020
  • Publish Date: 21 April 2013

Share

How to cite

Statistics